Histogenics Management Team

The Histogenics team has broad expertise and a record of successful innovation in many fields related to the development and manufacture of neocartilage products, including biotechnology, tissue engineering and medical devices.

• Kirk Andriano, Ph.D.
  VP of Research and Development
• Laurence Berlowitz Tarrant, Ph.D.
  Chief Scientific Officer and Founder
• Brian Callahan
  VP of Clinical, Regulatory and Quality
• Kevin McArdle
  Chief Financial Officer
• Patrick O’Donnell
  President and Chief Executive Officer
• Peter Hamilton
  V.P. of Manufacturing and Production